INTRODUCTION AND OBJECTIVES: Reactive oxygen species (ROS) have been identified as important chemical mediators in cell growth and differentiation. The glutathione redox system is the main mechanism protecting against damage caused by ROS in the human body. In this study, we investigated the role and therapeutic potential of the glutathione redox system in bladder cancer.
INTRODUCTION AND OBJECTIVES: Reactive oxygen species (ROS) have been identified as important chemical mediators in cell growth and differentiation. The glutathione redox system is the main mechanism protecting against damage caused by ROS in the human body. In this study, we investigated the role and therapeutic potential of the glutathione redox system in bladder cancer.
METHODS: The expression levels of glutathione peroxidase 2 (GPX2) and Ki-67 proteins were analyzed in human transurethral resection (TUR) specimens by immunohistochemistry; correlations between the GPX2 expression and prognosis were also analyzed. In addition, male F344 rats were given 0.05% BBN in drinking water and 0.1% Phenyl isothiocyanate in their diet for 36 weeks. Bladder tissue samples were collected from each animal for analyses. Furthermore, the rat cell line, BC31, and human cell lines, T24, RT4, TCC-SUP, and 5637, were transfected with GPX2 siRNA and negative control siRNA (NC). Subsequently, cell proliferation rates and ROS levels were investigated by cell counting, DCFH assay, western blotting, and flow cytometry. siRNA-or NC-transfected BC31 cells were subcutaneously implanted into nude mice.
RESULTS: GPX2 was strongly expressed in low grade and low MIB-1 index cancers. PFS and CSS rates were significantly better in patients with higher GPX2 than in those with lower GPX2. Furthermore, GPX2 expression was significantly lower in the normal epithelium of the control group of animals with bladder cancer when compared with those in the treated group, and GPX2 expression was significantly higher in urothelial cancer than in the normal epithelium. BC31 and RT4 cells strongly expressed GPX2 when compared with the other cell lines. Silencing of GPX2 caused significant growth inhibition, and the DCFH assay revealed significant reductions in ROS levels in the siRNAtreated cells. Caspase-dependent apoptosis was fund to be the cause for the decrease in proliferation rates in the siRNA group. Interestingly, tumor growth was significantly inhibited in the BC31-implanted nude mice using the siRNA strategy for Gpx2.
CONCLUSIONS: Our findings demonstrated that GPX2 plays several important roles in carcinogenesis through the regulation of apoptosis against intracellular ROS, and may be considered as a novel marker or therapeutic target in bladder cancer. INTRODUCTION AND OBJECTIVES: In the US, men are 3 to 4 times more likely to be diagnosed with bladder cancer (BC), however, women frequently present with more advanced disease and have inferior clinical outcomes. Recent data indicates androgen (AR) and estrogen receptors (ERa and ERb) play an important role in BC tumorigenesis and progression. These hormone receptors physically interact with transcription factor Forkhead box A1 (FOXA1), playing an important role in transcriptional activity of AR and ER. While the role for FOXA1/AR/ER complexes in BC is unknown, Foxa1 knockout (KO) results in sex-specific changes in murine urothelial differentiation. Interestingly, BC development in mice exposed to the carcinogen N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) also occurs in a sexdependent manner. Therefore, we initiated a study to determine the impact of Foxa1 KO on sex-dependent development of BC in mice.
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METHODS: To determine the effect of Foxa1 KO on BC development in males and females, Foxa1 ablation was achieved using a tamoxifen-inducible ubiquitin Cre (UBC-CreERT2) system. Control and KO mice were then exposed to BBN for 16 weeks and bladders were harvested for H&E, immunohistochemistry (IHC), and qPCR. RESULTS: Following 16 weeks of BBN treatment, female control mice appeared relatively resistant to carcinogenesis compared to males, which exhibited pre-neoplastic changes including keratinizing squamous metaplasia. However, Foxa1 KO followed by BBN treatment resulted in development of keratinizing squamous metaplasia in females and progression to muscle invasive BC in males. IHC for Krt14 and Ki67 confirmed the presence of squamous differentiation and increased proliferative index in both male and female Foxa1 KO mice treated with BBN. Interestingly, our analysis also shows that nuclear AR expression is increased in male control bladder tissue compared to female control bladder tissue. However, Foxa1 KO increases AR expression independent of sex.
CONCLUSIONS: Overall, our data indicates that Foxa1 KO in adult male and female mice renders them more susceptible to carcinogen exposure. Interestingly, Foxa1 KO resulted in development of keratinizing squamous metaplasia in female mice. Additionally, AR was slightly increased in Foxa1 KO mice, independent of sex. These data indicate loss of FOXA1 in human BC may be associated with increased AR expression and activity, and subsequent disease progression. Future work includes determining ERa and ERb expression following Foxa1 KO, as well as the mechanism by which Foxa1 KO alters AR expression and activity in BC.
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MP98-13 HOTAIR AFFECTS BLADDER CANCER EPITHELIAL-TO-MESENCHYME TRANSITION THROUGH BOTH THE CANONICAL WNT-PATHWAY AND EXTRACELLULAR VESICLES Thomas Osinski*, Claudia Berrondo, Jonathan Flax, Samuel Richheimer, Rochester, NY; Victor Kucherov, Philidelphia, PA; Carla Beckham, Rochester, NY INTRODUCTION AND OBJECTIVES: Previously we identified the long non-coding RNA Hox antisense intergenic transcript (HOTAIR) enriched in urothelial bladder cancer (UBC) cell lines, extracellular vesicles (ECVs), patient tumors and urinary ECVs. Importantly, HOTAIR affects the expression of genes involved in epithelial-tomesenchyme transition (EMT). Critically, we found reduced HOTAIR expression correlates with decreased in vitro migration and invasion.
e1316
THE JOURNAL OF UROLOGY â Vol. 197, No. 4S, Supplement, Tuesday, May 16, 2017 Many of the genes affected by HOTAIR expression are in the canonical Wnt-pathway. HOTAIR is a known to facilitate EMT through the canonical Wnt-pathway in other tumors. Determining the importance of the Wnt-pathway in UBC may open up new treatment options. Here we show that HOTAIR is necessary for Wnt-responsiveness and its expression increases during Wnt-pathway activation. EMT is also regulated through intercellular communication mediated by ECVs. Given HOTAIR regulates thousands of genes, we hypothesized that ECVs from HOTAIR knockdown cells would have limited ability to facilitate EMT. In fact, HOTAIR knockdown cells produce fewer exosomes with altered protein cargo and do not facilitate migration or invasion, suggesting that targeting of HOTAIR therapeutically would affect EMT through both the Wnt-pathway and ECVs functionality. Objective: To evaluate the role of HOTAIR in WNT-mediated and EVCmediated EMT METHODS: UBCs treated with LiCl or rWNT and gene expression was analyzed by qRTPCR, western blot and immunohistochemistry. We used scratch and 3D spheroid invasion assays to measure in vitro EMT in rWNT treated or untreated UBC cells. shRNA or siRNA against HOTAIR were used and WNT target and antagonist gene expression was measured by qRT-PCR. Migration and invasion were measured using scratch wound assay and 3D spheroid assay. TCF7L2 binding sites were identified in the promoter region of HOTAIR by sequencing. siRNA against TCF7L2 or beta-catenin reduced HOTAIR expression. ECVs isolatedd by ultracentrifugation and sucrose gradient were analyzed using the Nanosight. ECVs protein analysis was performed with LC MS/MS mass spectrometry and western blot. EVC-mediated migration and invasion was evaluated by wound and 3D invasion assay.
RESULTS: TCGA data reveals WNT pathway genes are affected in human UBC. LiCl or rWNT treated UBCs have increased EMT related gene expression. rWnt facilitates UBC in vitro migration and invasion in a HOTAIR-dependent fashion. Reduced HOTAIR expression correlates with decreased WNT-target and increased WNTantagonist gene expression. Importantly, HOTAIR is a target of canonical WNT signaling. Reduced HOTAIR expression affects UBC EVC number, content and in vitro migration and invasion.
CONCLUSIONS: These data support a role for the canonical WNT-pathway in UBC in a manner dependent on HOTAIR expression. Therefore, therapeutic targeting of the WNT-pathway may affect UBC tumor progression through reduced HOTAIR expression. Importantly, loss of HOTAIR affects the expression of hundreds of genes that results in reduced ECVs number, content, and ability to affect in vitro migration and invasion. CD25+Foxp3+ percentage in total CD4+ T cells, P<0.005) Tregs, and lower levels of tumor (13.16AE0.90% vs. 19.58AE1.46% Ki67+ area, P<0.002) and splenic cell (14.31AE1.18 vs. 18.82AE1.00% Ki67+ area, P¼0.008) proliferation than mice that received saline-treated Tregs. In vitro, inhibitor-treated Tregs showed lower proliferation and higher apoptosis than saline-treated Tregs when cells were exposed to MB49. In contrast, both types of Tregs showed no difference in proliferation when they were co-cultured with normal splenocytes. Inhibitor-treated Tregs had less apoptosis in splenocytes, but more apoptosis in splenocytes with MB49 conditioned media than saline-treated Tregs. In turn, we detected less proliferation and more apoptosis of MB94 cells after co-culture with inhibitor-treated Tregs, compared with saline-treated Tregs. B220+ B-cell proliferation and apoptosis, CD4+ T-cell proliferation and apoptosis, and CD8+ T-cell proliferation and apoptosis were also lower in splenocytes co-cultured with inhibitor-treated Tregs than with saline-treated Tregs. Under the same conditions, the addition of cancer cell-conditioned media greatly increased CD8+ T-cell proliferation (25.80AE0.65 vs. 16.60AE0.46% CD45.1eCD8+Ki67+ cells, P<0.001) and reduced CD8+ T-cell apoptosis (17.60AE0.26 vs. 20.40AE0.55% CD45.1eCD8+Annexin V+ cells, P¼0.021).
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MP98-14 CATHEPSIN S INHIBITION CHANGES REGULATORY T-CELL ACTIVITY IN REGULATING BLADDER CANCER AND IMMUNE CELL PROLIFERATION AND APOPTOSIS
CONCLUSIONS: CatS inhibition of Tregs may reduce overall Tcell immunity under normal conditions, but enhance CD8+ T-cell immunity in the presence of cancer cells.
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MP98-15 NUCLEAR PROTHYMOSIN-a CAN ENHANCE PTEN EXPRESSION TRANSCRIPTIONALLY AND NRF2 EXPRESSION THROUGH INHIBITING TRIM-21-MEDIATED UBIQUITINATION IN HUMAN BLADDER CANCER
Yuh-Shyan Tsai, Shih-Kai Lan*, Hsin-Tzu Tsai, Tzong-Shin Tzai, Tainan, Taiwan INTRODUCTION AND OBJECTIVES: Prothymosin-a(PTMA) is a nuclear protein that is usually transported into the nucleus and involves many biologic functions. We previously reported loss of nuclear PTMA protein or cytoplasmic accumulation is significantly associated with poor patients' survival in human urothelial carcinoma. The underlying molecular mechanisms were explored.
METHODS: Paraffin-embedded tumors were collected from 151 bladder cancer patients for PTMA immunostaining. The correlates with clinicopathologic characteristics and patients' survival were explored. Either ectopic nuclear, or cytoplasmic PTMA expression in human bladder cancer J82 cells were used for in vivo tumorigenesis assays and analysis of mRNA differential array. PTMA immunoblot from BFTC905 bladder cancer cells was investigated with proteomics and Tripartite motif-containing protein 21(TRIM21) was further explored the biological significance of the interaction with PTMA.
RESULTS: Loss of nuclear PTMA expression was significantly associated with tumor grade (p¼0.01), stage (p¼0.01), and was an independent prognostic indicator for short disease-free survival (HR, 1.54; 95% CI 1.12-2.12; p¼0.009). In vivo tumorigenesis study showed cytoplasmic PTMA-expressing J82 xenografts exhibit significantly more rapid tumor growth and shorted survival than those with nuclear PTMAexpressing ones (p<0.05). Chromatin immunoprecipitation study showed nuclear PTMA protein rather than cytoplasmic one can bind with and enhance PTEN promoter expression. Nuclear PTMA expression in bladder tumors exhibited higher PTEN mRNA levels. Immunoprepicitation studies confirmed nuclear PTMA can bind with TRIM21 and PTMA can enhance TRIM21 and NRF2 expression in dosedependent manner though inhibiting TRIM-21-mediated ubiquitination. The metaanalysis from 2 published datasets showed PTMA expression correlates with NRF2-targeted NAD(P)H quinone dehydrogenase 1(NQO1) expression (p¼0.009).
CONCLUSIONS: In this study we demonstrated that loss of nuclear PTMA expression decreased disease-free survival in bladder cancer. Nuclear PTMA can enhance PTEN expression transcriptionally
